Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
04 Mar 20264 min read0 viewsINTERVENTIONAL Trial
GIST (Key Takeaways)
RECRUITING · INTERVENTIONAL · TREATMENT study · Diabetes Mellitus, Type 1 · Phase 3 · Enrollment 60 · Sponsor: University of Colorado, Denver
Clinical Editorial
ClinicalTrials.gov published a clinical update in Cardiology on 04 Mar 2026. The item focuses on Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes. Open the detail page to review the full original feed content.
Source Reference
Read the full original publication from the source journal or publisher link below.